La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Hanmi Science Bilan de santé
Santé financière contrôle des critères 3/6
Hanmi Science has a total shareholder equity of ₩816.0B and total debt of ₩213.0B, which brings its debt-to-equity ratio to 26.1%. Its total assets and total liabilities are ₩1,252.9B and ₩436.9B respectively. Hanmi Science's EBIT is ₩56.0B making its interest coverage ratio 5.8. It has cash and short-term investments of ₩31.5B.
Informations clés
26.1%
Ratio d'endettement
₩212.98b
Dette
| Ratio de couverture des intérêts | 5.8x |
| Argent liquide | ₩31.55b |
| Fonds propres | ₩816.02b |
| Total du passif | ₩436.85b |
| Total des actifs | ₩1.25t |
Mises à jour récentes de la santé financière
Here's Why Hanmi Science (KRX:008930) Can Manage Its Debt Responsibly
Aug 13
Is Hanmi Science (KRX:008930) Using Too Much Debt?
Apr 29We Think Hanmi Science (KRX:008930) Can Stay On Top Of Its Debt
Jan 05Recent updates
Here's Why Hanmi Science (KRX:008930) Can Manage Its Debt Responsibly
Aug 13Hanmi Science Co., Ltd. (KRX:008930) Not Flying Under The Radar
Jul 22Is Hanmi Science (KRX:008930) Using Too Much Debt?
Apr 29Hanmi Science Co., Ltd.'s (KRX:008930) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Jan 31
We Think Hanmi Science (KRX:008930) Can Stay On Top Of Its Debt
Jan 05Shareholders Are Thrilled That The Hanmi Science (KRX:008930) Share Price Increased 100%
Dec 06Analyse de la situation financière
Passif à court terme: A008930's short term assets (₩271.1B) do not cover its short term liabilities (₩394.3B).
Passif à long terme: A008930's short term assets (₩271.1B) exceed its long term liabilities (₩42.6B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: A008930's net debt to equity ratio (22.2%) is considered satisfactory.
Réduire la dette: A008930's debt to equity ratio has increased from 6.2% to 26.1% over the past 5 years.
Couverture de la dette: A008930's debt is not well covered by operating cash flow (11.4%).
Couverture des intérêts: A008930's interest payments on its debt are well covered by EBIT (5.8x coverage).